MMP9 and Cognitive impairment: We used only one test to assess positive symptoms (i.e., MK-801-induced hyperlocomotion), one test to assess cognitive deficits (i.e., novel object recognition test), and two tests to evaluate negative symptoms in Mmp-9 heterozygous mice.